Evidence map›Paper›PMID 29130116›Full record

ReviewPediatric nephrology (Berlin, Germany)2018

Hearing loss and renal syndromes.

Paul J Phelan, Michelle N Rheault

Abstract readReview
PubMed Publisher
In one paragraph

Review in Pediatric nephrology (Berlin, Germany), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Case Report: Wide spectrum ofFrontiers in pediatrics · 2025
    Article
  4. PGC-1Acta pharmaceutica Sinica. B · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Multidisciplinary Management of Alport Syndrome: Current Perspectives.Journal of multidisciplinary healthcare · 2021
    Review
  9. Article
  10. Review
  11. [An epidemiological investigation of chronic kidney disease in children with hearing disorder in Hunan province, China].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Paul J PhelanDepartment of Nephrology, Royal Infirmary of Edinburgh, NHS Lothian, Edinburgh, UK.
Michelle N RheaultDepartment of Pediatrics, Division of Nephrology, University of Minnesota Masonic Children's Hospital, Minneapolis, MN, USA. rheau002@umn.edu.ORCID 0000-0003-2494-3970

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The association between ear and kidney abnormalities has long been recognized; however, the connection between these two disparate organs is not always straightforward. Although Alport syndrome is the most well-known, there are over 20 disorders that need to be considered in the differential diagnosis of patients with both ear and kidney abnormalities. Commonalities are present between the kidney and ear in a number of structural proteins, developmentally important transcription factors, ciliary proteins, and channel proteins, and mutations in these pathways can lead to disease in both organ systems. This manuscript reviews the congenital disorders with both hearing and kidney manifestations.

Indexed as

CiliaDiagnosis, DifferentialEar, InnerEpithelial CellsHearing LossHumansKidneyKidney DiseasesMembrane Transport ProteinsMutationSyndromeTranscription FactorsMembrane Transport ProteinsTranscription FactorsAlport syndromeCongenital anomalies of the kidney and urinary tractSensorineural hearing loss

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.